Dr. Reddy's Laboratories (ADR) (RDY)
Produces generics, branded medicines, biosimilars, active ingredients, and consumer health products.
$12.57
After-hours close0.00 (0.00%)
At close$12.57(+1.37%)
In millions of USD, except per-share figures · converted from INR at the latest rate
| In millions | Q2 FY24Sep 2023 | Q3 FY24Dec 2023 | Q4 FY24Mar 2024 | Q1 FY25Jun 2024 | Q2 FY25Sep 2024 | Q3 FY25Dec 2024 | Q4 FY25Mar 2025 | Q1 FY26Jun 2025 | Q2 FY26Sep 2025 | Q3 FY26Dec 2025 | Q4 FY26Mar 2026 | Q1 FY27Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 755 | 741 | 803 | 839 | 875 | 890 | 894 | 921 | 913 | 799 | 849 |
| Cost of revenue | 4 | 313 | 307 | 318 | 339 | 361 | 395 | 385 | 418 | 423 | 441 | 454 |
| Gross profit | 5 | 442 | 434 | 485 | 500 | 513 | 494 | 509 | 504 | 490 | 358 | 395 |
| 3 | 261 | 278 | 297 | 316 | 317 | 310 | 326 | 320 | 341 | 353 | 364 | |
| Research & development | 1 | 58 | 72 | 65 | 76 | 70 | 76 | 65 | 65 | 64 | 58 | 61 |
| 2 | 212 | 214 | 237 | 241 | 252 | 252 | 243 | 277 | 282 | 295 | 303 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 243 | 0 | 0 | 0 | 0 |
| Other expenses | 0 | −9 | −9 | −5 | −1 | −5 | −18 | 18 | −21 | −5 | 0 | 0 |
| Operating income | 2 | 181 | 157 | 188 | 184 | 196 | 185 | 183 | 183 | 149 | 5 | 31 |
| 1 | 10 | 11 | 9 | 17 | 0 | 25 | 16 | 9 | 12 | 16 | 27 | |
| Interest income | 8 | 6 | 7 | 8 | 7 | 7 | 6 | 12 | 18 | 22 | 18 | 31 |
| Interest expense | 4 | 4 | 6 | 6 | 8 | 9 | 7 | 9 | 9 | 10 | 11 | 13 |
| Other non-operating income | −1 | −14 | −17 | 0 | −25 | −9 | −32 | −25 | −18 | −3 | −27 | 0 |
| Income before tax | 2 | 191 | 168 | 197 | 201 | 196 | 210 | 199 | 192 | 161 | 21 | 58 |
| Income tax expense | 1 | 47 | 31 | 51 | 60 | 49 | 44 | 52 | 43 | 37 | −2 | 12 |
| Net income from continuing operations | 2 | 144 | 137 | 146 | 140 | 147 | 166 | 147 | 149 | 124 | 23 | 46 |
| Net income | 2 | 144 | 137 | 146 | 131 | 148 | 167 | 148 | 150 | 127 | 23 | 47 |
| EPS, basic | $0.19 | $0.17 | $0.16 | $0.17 | $0.16 | $0.18 | $0.20 | $0.18 | $0.18 | $0.15 | $0.03 | $0.06 |
| EPS, diluted | $0.19 | $0.17 | $0.16 | $0.17 | $0.16 | $0.18 | $0.20 | $0.18 | $0.18 | $0.15 | $0.03 | $0.06 |
| Weighted average shares, basic | 832 | 833 | 833 | 834 | 834 | 833 | 833 | 832 | 832 | 833 | 835 | 833 |
| Weighted average shares, diluted | 834 | 834 | 834 | 834 | 834 | 834 | 834 | 833 | 833 | 833 | 835 | 833 |
| EBITDA | 3 | 235 | 213 | 228 | 250 | 254 | 264 | 258 | 254 | 205 | 92 | 31 |
| Depreciation & amortization | 0 | 39 | 39 | 40 | 42 | 49 | 48 | 50 | 53 | 53 | 59 | 0 |
| EBIT | 2 | 195 | 174 | 187 | 208 | 205 | 217 | 208 | 201 | 152 | 32 | 31 |